Cases & Deals

Jefferies International, Kempen, and KBC complete €42 million share placing by Ablynx

Clients Jefferies International Limited, KBC Securities NV, and Kempen & Co N.V.

Jones Day represented Jefferies International Limited, KBC Securities NV, and Kempen & Co N.V. in connection with the sale of shares in an accelerated book build placing by Ablynx NV, a biotechnology company focused on the discovery and development of a novel class of antibody-derived therapeutic proteins based on single-domain antibody fragments for a range of serious human diseases including inflammation, haematology, oncology, and pulmonary disease.